Eli Lilly and Company (LLY)
NYSE: LLY · Real-Time Price · USD
711.68
+1.86 (0.26%)
At close: Aug 22, 2025, 4:00 PM
711.15
-0.53 (-0.07%)
After-hours: Aug 22, 2025, 7:59 PM EDT
Eli Lilly Employees
Eli Lilly and Company had 47,000 employees as of December 31, 2024. The number of employees increased by 4,000 or 9.30% compared to the previous year.
Employees
47,000
Change (1Y)
4,000
Growth (1Y)
9.30%
Revenue / Employee
$1,133,151
Profits / Employee
$293,615
Market Cap
638.90B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 47,000 | 4,000 | 9.30% |
Dec 31, 2023 | 43,000 | 4,000 | 10.26% |
Dec 31, 2022 | 39,000 | 4,000 | 11.43% |
Dec 31, 2021 | 35,000 | 0 | - |
Dec 31, 2020 | 35,000 | 1,375 | 4.09% |
Dec 31, 2019 | 33,625 | -5,055 | -13.07% |
Dec 31, 2018 | 38,680 | -1,975 | -4.86% |
Dec 31, 2017 | 40,655 | -1,320 | -3.14% |
Dec 31, 2016 | 41,975 | 700 | 1.70% |
Dec 31, 2015 | 41,275 | 2,140 | 5.47% |
Dec 31, 2014 | 39,135 | 1,210 | 3.19% |
Dec 31, 2013 | 37,925 | -425 | -1.11% |
Dec 31, 2012 | 38,350 | 270 | 0.71% |
Dec 31, 2011 | 38,080 | -270 | -0.70% |
Dec 31, 2010 | 38,350 | -2,010 | -4.98% |
Dec 31, 2009 | 40,360 | -140 | -0.35% |
Dec 31, 2008 | 40,500 | -100 | -0.25% |
Dec 31, 2007 | 40,600 | -900 | -2.17% |
Dec 31, 2006 | 41,500 | -1,100 | -2.58% |
Dec 31, 2005 | 42,600 | -1,900 | -4.27% |
Dec 31, 2004 | 44,500 | -1,600 | -3.47% |
Dec 31, 2003 | 46,100 | 2,400 | 5.49% |
Dec 31, 2002 | 43,700 | 2,600 | 6.33% |
Dec 31, 2001 | 41,100 | 5,400 | 15.13% |
Dec 31, 2000 | 35,700 | 4,400 | 14.06% |
Dec 31, 1999 | 31,300 | 1,500 | 5.03% |
Dec 31, 1998 | 29,800 | -1,300 | -4.18% |
Dec 31, 1997 | 31,100 | 1,900 | 6.51% |
Dec 31, 1996 | 29,200 | 2,400 | 8.96% |
Dec 31, 1995 | 26,800 | 1,900 | 7.63% |
Dec 31, 1994 | 24,900 | -7,800 | -23.85% |
Dec 31, 1993 | 32,700 | 500 | 1.55% |
Dec 31, 1992 | 32,200 | 1,400 | 4.55% |
Dec 31, 1991 | 30,800 | 1,300 | 4.41% |
Dec 31, 1990 | 29,500 | 1,700 | 6.12% |
Dec 31, 1989 | 27,800 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
LLY News
- 17 hours ago - Lilly to participate in Wells Fargo 20th Annual Healthcare Conference - PRNewsWire
- 1 day ago - Eli Lilly and Company Investors: Company Investigated by the Portnoy Law Firm - GlobeNewsWire
- 2 days ago - Healthcare Stocks Are Trading at Their Biggest Discount in 30 Years. Why a Turnaround May Have Already Started. - Barrons
- 2 days ago - Anne White to Retire as Executive Vice President and President, Lilly Neuroscience - PRNewsWire
- 2 days ago - Pharmaceuticals Industry Analysis: Eli Lilly Tops My Tier Two - Seeking Alpha
- 3 days ago - New Obesity Drugs May See Premium Pricing Undermined By Underwhelming Data - Benzinga
- 3 days ago - Like Eli Lilly, Viking Therapeutics' Oral Weight Loss Drug Disappoints, Stock Tanks - Benzinga
- 4 days ago - Novo Nordisk's Loss Is Eli Lilly's Gain, And Vice Versa - Seeking Alpha